Christopher M Kramer1. 1. Department of Radiology, University of Virginia Health System, Charlottesville, VA 22908, USA. ckramer@virginia.edu
Abstract
INTRODUCTION: Peripheral arterial disease (PAD) is characterized by lower limb arterial obstruction due to atherosclerosis and is increasingly common. Presently used methods for diagnosis and follow-up as well as for assessment of novel therapies are limited. MATERIALS AND METHODS: Three distinct magnetic resonance examinations were developed. The first was high-resolution black-blood atherosclerotic plaque imaging of the superficial femoral artery using a surface coil and flow saturation. Second, first-pass contrast-enhanced dual-contrast perfusion imaging of the calf muscle was performed at peak exercise using a magnetic resonance (MR)-compatible pedal ergometer. Lastly, (31)P MR spectroscopy was also performed at peak exercise to measure phosphocreatine (PCr) recovery kinetics. RESULTS: Seventeen patients (age, 63 +/- 10 yrs) with mild to moderate PAD were studied with black-blood atherosclerotic plaque imaging. Mean atherosclerotic plaque volume measured was 7.27 +/- 3.73 cm(3). Eleven patients (age, 61 +/- 11 yrs) with mild to moderate symptomatic PAD and 22 normal control subjects were studied with first-pass contrast-enhanced perfusion imaging. Perfusion index was stepwise increased from patients to normal subjects with matched workload to normal subjects at maximal exercise. For PCr recovery kinetics, 20 patients with mild to moderate PAD and 14 controls were studied. The median recovery time constant of PCr was 34.7 seconds in the controls and 91.0 seconds in the PAD patients (P < 0.0001). CONCLUSIONS: Three distinct MR examinations of different aspects of peripheral arterial disease have been developed and tested and shown to differentiate patients with mild to moderate PAD from normal controls. Taken together, these tests are potential quantitative end points for clinical trials of novel therapies in PAD.
INTRODUCTION:Peripheral arterial disease (PAD) is characterized by lower limb arterial obstruction due to atherosclerosis and is increasingly common. Presently used methods for diagnosis and follow-up as well as for assessment of novel therapies are limited. MATERIALS AND METHODS: Three distinct magnetic resonance examinations were developed. The first was high-resolution black-blood atherosclerotic plaque imaging of the superficial femoral artery using a surface coil and flow saturation. Second, first-pass contrast-enhanced dual-contrast perfusion imaging of the calf muscle was performed at peak exercise using a magnetic resonance (MR)-compatible pedal ergometer. Lastly, (31)P MR spectroscopy was also performed at peak exercise to measure phosphocreatine (PCr) recovery kinetics. RESULTS: Seventeen patients (age, 63 +/- 10 yrs) with mild to moderate PAD were studied with black-blood atherosclerotic plaque imaging. Mean atherosclerotic plaque volume measured was 7.27 +/- 3.73 cm(3). Eleven patients (age, 61 +/- 11 yrs) with mild to moderate symptomatic PAD and 22 normal control subjects were studied with first-pass contrast-enhanced perfusion imaging. Perfusion index was stepwise increased from patients to normal subjects with matched workload to normal subjects at maximal exercise. For PCr recovery kinetics, 20 patients with mild to moderate PAD and 14 controls were studied. The median recovery time constant of PCr was 34.7 seconds in the controls and 91.0 seconds in the PAD patients (P < 0.0001). CONCLUSIONS: Three distinct MR examinations of different aspects of peripheral arterial disease have been developed and tested and shown to differentiate patients with mild to moderate PAD from normal controls. Taken together, these tests are potential quantitative end points for clinical trials of novel therapies in PAD.
Authors: Judith G Regensteiner; John E Ware; Walter J McCarthy; Peter Zhang; William P Forbes; Jeffrey Heckman; William R Hiatt Journal: J Am Geriatr Soc Date: 2002-12 Impact factor: 5.562
Authors: Jian-Ming Cai; Thomas S Hatsukami; Marina S Ferguson; Randy Small; Nayak L Polissar; Chun Yuan Journal: Circulation Date: 2002-09-10 Impact factor: 29.690
Authors: Jean-Claude Tardif; Jean Grégoire; Jacques Lespérance; Jean Lambert; Philippe L L'Allier; Josep Rodés; Todd Anderson; John W Blue; James Imus; Therese Heinonen Journal: Am Heart J Date: 2002-10 Impact factor: 4.749
Authors: D Walter Wray; Steven K Nishiyama; Aurélien Monnet; Claire Wary; Sandrine S Duteil; Pierre G Carlier; Russell S Richardson Journal: Am J Physiol Heart Circ Physiol Date: 2009-09-18 Impact factor: 4.733
Authors: Brad J Behnke; Leonardo F Ferreira; P J McDonough; Timothy I Musch; David C Poole Journal: Respir Physiol Neurobiol Date: 2009-07-18 Impact factor: 1.931
Authors: D Walter Wray; Steven K Nishiyama; Aurélien Monnet; Claire Wary; Sandrine Duteil; Pierre G Carlier; Russell S Richardson Journal: J Gerontol A Biol Sci Med Sci Date: 2009-04-17 Impact factor: 6.053
Authors: Fabian Niess; Albrecht Ingo Schmid; Wolfgang Bogner; Michael Wolzt; Pierre Carlier; Siegfried Trattnig; Ewald Moser; Martin Meyerspeer Journal: Magn Reson Med Date: 2019-12-17 Impact factor: 4.668